Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402

Cell Research

Volumn 14, Issue 1, 2004, Pages 74-80

  Zhao, Dong Hong ^a   Hong, Jian Jun ^a   Guo, Shi Ying ^a   Yang, Run Lin ^a   Yuan, Jun ^a   Wen, Chuan Jun ^a   Zhou, Kai Ya ^a   Li, Chao Jun ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

catenin; Dominant negative TCF4; Wnt signaling pathway

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; CYCLIN D1; CYTOSKELETON PROTEIN; DNA BINDING PROTEIN; LYMPHOID ENHANCER FACTOR 1; MYC PROTEIN; MYC PROTEIN, HUMAN; ONCOPROTEIN; T CELL FACTOR PROTEIN; TCF4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; WNT PROTEIN;

ARTICLE; CELL DIVISION; CELL LINE; CHEMISTRY; CYTOPLASM; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPECTROFLUOROMETRY; TUMOR CELL LINE; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CYCLIN D1; CYTOPLASM; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICROSCOPY, FLUORESCENCE; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPECTROMETRY, FLUORESCENCE; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; WNT PROTEINS;

EID: 16544373284     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7290205     Document Type: Article

References (24)

1. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryo-genesis -a look outside the nucleus. Science 2000; 287:1606-9.
2. Pennisi E. How a growth control path takes a wrong turn to cancer. Science 1998; 281(5382):1438-9.
3. Hulsken J, Behrens J. The Wnt signaling pathway. J Cell Science 2000; 123:3545-9.
4. Huber AH, Weis WI. The structure of the β-catenin /E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 2001; 105:391-402.
5. Korinek V, Barker NPJ, Morin D et al. Constitutive transcriptional activation by a beta-catenin-TCF complex in APC(-/-) colon carcinoma. Science 1997; 275:1784-7.
6. Rubinfeld B, Albert I, Porfiri E. Binding of GSK3 β to the APC β-catenin complex and regulation of complex assembly. Science 1996; 272:1023-6
7. Nakamura T et al. Axin, an inhibitor of the Wnt signalling pathway, interacts with β-catenin, GSK-3β and APC and reduces the β-catenin level. Genes Cells 1998; 3:395-403
8. Morin PJ, Sparks AB, Korinek V. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 75:1787-90
9. Ferruccio G, Volonte D, Brown AMC et al. Caveolin-1 expression inhibits Wnt/β-catenin/Lef-1 signaling by recruiting β-catenin to caveolae membrane domains. J Biol Chem 2000; 275(30):23368-77.
10. Rubinfeld B, Albert I, Porfiri E. Binding of GSK3 β to the APC β-catenin complex and regulation of complex assembly. Science 1996; 272:1023-6.
11. Koch A, Denkhaus D and Albrecht S et al. Childhood hepatoblastomas frequently carry mutated degradation targeting box of the β-catenin gene. Cancer Res 1999, 59:269-73.
12. Satoh S, Daigo Y, Furukawa Y et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000; 24(3):245-50.
13. Lawrence S. Beta-catenin and its multiple partners: promiscuity explained. Nature Stru Biol 2001; 8:484-7.
14. Mann B, Gelos M, Siedow A et al. Target genes of beta-catenin-T cell-factor/lymphoid enhancer factor signaling in human colorectal carcinomas. Proc Natl Acad Sci 1999; 96:1603-8.
15. Charles , Omer, Patricia J, Miller, Ronald E Diehl, Astrid M, Kral. Identification of TCF4 Residues Involved in High-Affinity β-catenin Binding. Biochem Biophy Res Comm 1999; 256(3): 584-90.
16. Skehan P, Storeng R, Scudiero D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Nat Cancer Inst 1990; 82:1107-12.
17. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 2002; 90(3):340-7.
18. Xu XR, Huang J, Xu ZG et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci 2001; 98(26):15089-94.
19. Coste A, Romagnolo B, Billuart P et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Science 1998; 95:8847-51.
20. Graham TA, Ferkey DM, Mao F, Kimelman D, Xu W. TCF4 can specifically recognize beta-catenin using alternative conformations. Nat Struct Biol 2001; 8(12):1048-52.
21. Harada N, Miyoshi H, Murai N et al. Lack of Tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-Catenin. Cancer Res 2002; 62(7): 1971-7.
22. Hovanes K, Li TW, Munguia JE et al. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 2001; 28:53-7.
23. Tetsu O, McCormick F. beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398:422-6.
24. He TC, Sparks AB, Rago C et al. Identification of c-Myc as a target of the APC pathway. Science 1998; 281:1509-12.